Somatic sex determination (WP4814)

Homo sapiens

This pathway describes the sex determination in a fetus. For the male development the SRY gene plays an important role, leading to the SOX9 expression which will then stimulate AMH expression and testis development. In adults DMRT1 and SOX9 inhibit the FOXL2 gene, maintaining the male sex determination. For the female development the WNT4 and RSPO1 signaling pathways lead to beta-catenin accumulation which inhibits SOX9 and the development of ovaries. In adults, Foxl2 repress Sox9 expression to maintain ovarian identity.

Authors

Je G , Friederike Ehrhart , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Rare Diseases

Annotations

Pathway Ontology

signaling pathway

Disease Ontology

disorder of sexual development

Participants

Label Type Compact URI Comment
DHH GeneProduct ensembl:ENSG00000139549
FOXL2 GeneProduct ensembl:ENSG00000183770
SOX9 GeneProduct ensembl:ENSG00000125398
AMH GeneProduct ensembl:ENSG00000104899
WNT4 GeneProduct ensembl:ENSG00000162552
GATA4 GeneProduct ensembl:ENSG00000136574
SRY GeneProduct ensembl:ENSG00000184895
NR5A1 GeneProduct ensembl:ENSG00000136931
RSPO1 GeneProduct ensembl:ENSG00000169218
WT1 GeneProduct ensembl:ENSG00000184937
SOX8 GeneProduct ensembl:ENSG00000005513
FGF9 GeneProduct ensembl:ENSG00000102678
DMRT1 GeneProduct ensembl:ENSG00000137090
PTGDS GeneProduct ensembl:ENSG00000107317

References

  1. Mechanism of Sex Determination in Humans: Insights from Disorders of Sex Development. Bashamboo A, McElreavey K. Sex Dev. 2016;10(5–6):313–25. PubMed Europe PMC Scholia